Head-to-head · WeighScore
bmiMD vs NEUVÉ Health
By GLP-1 ScorecardUpdated
Score comparison
bmiMD has the higher recorded score — 79.2/100 to 64.7/100.
bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | bmiMD | NEUVÉ Health |
|---|---|---|
| WeighScore | 79.2/100 | 64.7/100 |
| Grade | C+ | C |
| Site position | #29 | #260 |
| Semaglutide | $159/mo month-to-month ($119/mo equivalent with $1,428 prepaid for 12 months) | $179/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Tirzepatide | $249/mo month-to-month ($179/mo equivalent with $2,148 prepaid for 12 months) | $240/mo (injectable microdose with B12; the site gives three answers on whether medication is included) |
| Coverage | All 50 states | All 50 states (claimed; the same page says members in 40+ states) |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #29 · C+
Strengths
- Advertises the same price across prescribed doses for each selected injection plan
- Publishes compounded semaglutide and tirzepatide injection plans
- Every rung of both ladders is published with the total charge beside each per-month figure
- All 50 states
What to consider
- The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
- The annual $119 and $179 monthly equivalents require $1,428 or $2,148 paid upfront for 12 months
- A struck-through $228.60 and $349.20 sit above the ladders under a standing LIMITED TIME label, with no published basis
- Neither the compounding pharmacy nor the prescribing group is named on the product pages
Site position #260 · C
Strengths
- The whole GLP-1 catalog is built around microdosing rather than offering it as an afterthought, with an injectable and a daily sublingual route at different prices
- Names its lab partners, Quest and LabCorp, and says panel pricing is confirmed before a charge
- States both compounding classes on the homepage rather than leaving the question open
- Names clinicians on the site and inside the matching step of the intake
- A large hormone, peptide and lab menu sits beside the GLP-1 lines
What to consider
- Three incompatible answers to whether medication is in the price: the weight-loss program page is headed “all-in monthly pricing” and its own fine print says medication, labs and supplies are billed separately
- Four different “from” floors are published across four pages, one of which belongs to the testosterone line rather than the GLP-1 one
- Three membership tiers — Core, Plus and Premium — are named once in the financial policy and priced nowhere
- The tirzepatide sublingual microdose card lists compounded sublingual semaglutide microdose in its own inclusion list
- Every legal page closes by saying it is plain-English summary copy under review by counsel and may change before public launch, on a site already taking intake
- “All 50 U.S. states” and “members in 40+ states” are printed on the same homepage without the distinction the About page draws
- Membership fees are non-refundable, and no pharmacy, medical group entity or NPI is named
Featured provider
bmiMD
bmiMD scores 79.2/100 (C+). bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.